Skip to main content
. Author manuscript; available in PMC: 2023 Sep 1.
Published in final edited form as: Am J Gastroenterol. 2022 Jun 10;117(9):1462–1470. doi: 10.14309/ajg.0000000000001869

Figure 1-. Overview of study population-.

Figure 1-

During the study period, there were 2272 patients enrolled into DILIN with 2012 who had HEV testing completed for analysis with 6 months of follow-up. HEV testing of baseline samples demonstrated that 18 (0.9%) were anti-HEV IgM (+) consistent with acute HEV infection, 389 (19.3%) were anti-HEV IgG + but anti-HEV IgM (−) consistent with prior HEV infection, and 1605 (79.8%) without prior HEV infection.